Skip to content
Search

Latest Stories

DH issues supply disruption notice for six oral contraceptive brands

The Department of Health and Social Care (DH) has issued a medicine supply notification for six oral contraceptive tablets of various brands.

The following oral contraceptive preparations are currently out of stock.


Product affectedIngredientsAnticipated Resupply DateManagement Advice
BrevinorEthinylestradiol/norethisterone 35microgram/500 microgram tabletsEarly January 2021No exact equivalent available
EloineEthinylestradiol/ drospirenone

20 microgram /3mg tablet

October 2020Unlicensed imports of Eloine have been sourced, lead times vary
NoriminEthinylestradiol/norethisterone 35microgram/1mg tabletsEarly January 2021No exact equivalent available
SynphaseEthinylestradiol/norethisterone/ 35microgram/500microgram and

35microgram/1mg tablets

Early January 2021Unlicensed imports of Synphase tablets have been sourced; lead times vary.
YiznellEthinylestradiol/drospirenone 30microgram/3mg tabletsNovember 2020Equivalent alternatives with same composition remain available from suppliers of following brands: Dretine, Yacella, Yasmin, Ellaite and Lucette.
ZoelyEstradiol/nomegestrol 1.5mg/2.5mg tabletsMid October 2020No exact equivalent available

The importers including Clinigen, Mawdsley’s Unlicensed, and Target Healthcare have confirmed that they can source unlicensed imports of Synphase tablets.

Community pharmacists can reach Alium, Mawdsley’s Unlicensed, Target Healthcare, and Durbin for unlicensed imports of Eloine tablets.

There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems so an EPS prescription for unlicensed Synphase tablets cannot be issued.

If a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘Ethinylestradiol/norethisterone/ 35microgram/500microgram and 35microgram/1mg tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special.

More For You

Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less
"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less